(iv) Fair value (v) Impairment Assets carried at amortized cost Available-for-sale financial investments (vi) Additional disclosures (vii) Comprehensive income new StandardS and interpretationS iSSued but not yet effective IFRS 9 Financial Instruments: Classification and Measurement IFRS 9 as issued reflects the first phase of the IASBs work on the replacement of IAS 39 and applies to classification and measurement  of financial assets and financial liabilities as defined in IAS 39. The standard is effective for annual periods beginning on or after January 1, 2013. In subsequent phases, the IASB will address hedge accounting and impairment of financial assets. The completion of  this project is expected over the course of 2011. Where the amendments to IFRS 9 would otherwise become mandatory for the  Company’s fiscal 2013 consolidated financial statements, the Company early adopted the IFRS 9 amendments issued to date as at the  (i) The Company has adopted the following new standards, amendments to standards and interpretations that have been issued but  are not yet effective, which have been applied in preparing these consolidated financial statements effective January 3, 2010: Comprehensive income includes the Company’s net income and other comprehensive income. Other comprehensive income includes  unrealized exchange gains and losses on translation of self-sustaining foreign operations and changes in the fair market value of  derivative instruments designated as cash flow hedges, net of applicable income taxes. The components of comprehensive income  are disclosed in the Consolidated Statements of Comprehensive Income and the Consolidated Statements of Changes in Equity. Disclosures regarding the risks arising from financial instruments are included in  note 24 . If an available-for-sale asset is impaired, an amount comprising the difference between its cost (net of any principal payment and  amortization) and its current fair value, less any impairment loss previously recognized in profit or loss, is transferred from other  comprehensive income to profit or loss. Reversals in respect of equity instruments classified as available-for-sale are not recognized  in profit or loss; increases in their fair value after impairment are recognized directly in other comprehensive income. Reversals of  impairment losses on debt instruments are reversed through profit or loss, if the increase in fair value of the instrument can be  objectively related to an event occurring after the impairment loss was recognized in profit or loss. In relation to trade receivables, a provision for impairment is made when there is objective evidence (such as the probability of  insolvency or significant financial difficulties of the debtor) that the Company will not be able to collect all of the amounts due under  the original terms of the invoice. The carrying amount of the receivable is reduced through use of an allowance account. Impaired  debts are derecognized when they are assessed as uncollectible. If, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event  occurring after the impairment was recognized, the previously recognized impairment loss is reversed, to the extent that the carrying  value of the asset does not exceed its amortized cost at the reversal date. Any subsequent reversal of an impairment loss is  recognized in profit or loss. If there is objective evidence that an impairment loss on assets carried at amortized cost has been incurred, the amount of the loss is  measured individually as the difference between the asset’s carrying amount and the present value of estimated future cash flows  (excluding future expected credit losses that have not been incurred) discounted at the financial asset’s original effective interest rate (the effective interest rate computed at initial recognition). The carrying amount of the asset is reduced through use of an  allowance account. The amount of the loss shall be recognized in profit or loss. If the Company determines that no objective evidence  of impairment exists for an individually assessed financial asset, whether significant or not, it includes the asset in a group of  financial assets with similar credit risk characteristics and collectively assesses them for impairment. Assets that are individually  assessed for impairment and for which an impairment loss is, or continues to be, recognized are not included in a collective  assessment of impairment. The Company assesses at each financial reporting date whether a financial asset or group of assets is impaired.  The fair value of investments that are actively traded in organized financial markets is determined by reference to quoted market bid prices at the close of business on the date of the statement of financial position. For investments where there is no active market,  fair value is determined by using valuation techniques. Such techniques include using recent arm’s-length market transactions;  reference to the current market value of another instrument that is substantially the same; discounted cash flow analysis or other  valuation models.  68 HIGH lIneR FooDS InCoRpoRAteD